Access

Review


Nature Medicine 8, 1235 - 1242 (2002)
doi:10.1038/nm1102-1235

The macrophage foam cell as a target for therapeutic intervention

Andrew C. Li1 & Christopher K. Glass1


Specialized functions of macrophages have evolved to protect the body from infection. However, the same mechanisms that enable phagocytosis of pathogens and activation of leukocytes also permit the uptake of lipoproteins and release of reactive oxygen species and immune mediators that collectively contribute to atherosclerosis. New approaches to inhibit lipid accumulation in macrophage foam cells and reduce inflammatory responses may be of therapeutic value in preventing coronary artery disease.


Macrophages are essential cellular components of the body's host defense system, having critical functions in both native and acquired immunity. As participants in innate immunity, macrophages protect the host during the early phase of an infection.

MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated

REFERENCE
Lipoproteins: Genetic Disorders
Nature Encyclopaedia of Life Sciences
Cardiovascular Disease and Congenital Heart Defects
Nature Encyclopaedia of Life Sciences
 See all 7 matches for Reference

REVIEWS
The liver X receptor gene team: Potential new players in atherosclerosis
Nature Medicine Review Article (01 Nov 2002)
 See all 8 matches for Reviews

NEWS AND VIEWS
Progress in cardiovascular biology: PPAR for the course
Nature Medicine News and Views (01 Jan 2001)
eLiXiRs for restraining inflammation
Nature Medicine News and Views (01 Feb 2003)
 See all 9 matches for News And Views

RESEARCH
PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway
Nature Medicine Article (01 Jan 2001)
 See all 29 matches for Research